Evidence map›Paper›PMID 37238175›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Prediction of Cognitive Decline in Parkinson's Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems.

Mahdi Hosseinzadeh, Arman Gorji, Ali Fathi Jouzdani, Seyed Masoud Rezaeijo, Arman Rahmim, Mohammad R Salmanpour

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Development of anQuantitative imaging in medicine and surgery · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahdi HosseinzadehTechnological Virtual Collaboration (TECVICO Corp.), Vancouver, BC V5E 3J7, Canada.ORCID 0000-0002-3255-3473
Arman GorjiNeuroscience and Artificial Intelligence Research Group (NAIRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan 6517838736, Iran.
Ali Fathi JouzdaniNeuroscience and Artificial Intelligence Research Group (NAIRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan 6517838736, Iran.
Seyed Masoud RezaeijoDepartment of Medical Physics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran.ORCID 0000-0002-4525-0025
Arman RahmimDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Mohammad R SalmanpourTechnological Virtual Collaboration (TECVICO Corp.), Vancouver, BC V5E 3J7, Canada.ORCID 0000-0002-9515-789X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to predict Montreal Cognitive Assessment (MoCA) scores in Parkinson's disease patients at year 4 using handcrafted radiomics (RF), deep (DF), and clinical (CF) features at year 0 (baseline) applied to hybrid machine learning systems (HMLSs).

methods297 patients were selected from the Parkinson's Progressive Marker Initiative (PPMI) database. The standardized SERA radiomics software and a 3D encoder were employed to extract RFs and DFs from single-photon emission computed tomography (DAT-SPECT) images, respectively. The patients with MoCA scores over 26 were indicated as normal; otherwise, scores under 26 were indicated as abnormal. Moreover, we applied different combinations of feature sets to HMLSs, including the Analysis of Variance (ANOVA) feature selection, which was linked with eight classifiers, including Multi-Layer Perceptron (MLP), K-Neighbors Classifier (KNN), Extra Trees Classifier (ETC), and others. We employed 80% of the patients to select the best model in a 5-fold cross-validation process, and the remaining 20% were employed for hold-out testing.

resultsFor the sole usage of RFs and DFs, ANOVA and MLP resulted in averaged accuracies of 59 ± 3% and 65 ± 4% for 5-fold cross-validation, respectively, with hold-out testing accuracies of 59 ± 1% and 56 ± 2%, respectively. For sole CFs, a higher performance of 77 ± 8% for 5-fold cross-validation and a hold-out testing performance of 82 + 2% were obtained from ANOVA and ETC. RF+DF obtained a performance of 64 ± 7%, with a hold-out testing performance of 59 ± 2% through ANOVA and XGBC. Usage of CF+RF, CF+DF, and RF+DF+CF enabled the highest averaged accuracies of 78 ± 7%, 78 ± 9%, and 76 ± 8% for 5-fold cross-validation, and hold-out testing accuracies of 81 ± 2%, 82 ± 2%, and 83 ± 4%, respectively.

conclusionsWe demonstrated that CFs vitally contribute to predictive performance, and combining them with appropriate imaging features and HMLSs can result in the best prediction performance.

Indexed as

deep learninghybrid machine learning systemsMontreal Cognitive AssessmentParkinson’s diseaseradiomics

Identifiers

PMID37238175
PMCPMC10217464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.